These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9703468)

  • 1. Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
    De Rosa M; Giordano S; Scettri A; Sodano G; Soriente A; Pastor PG; Alcaraz MJ; Payá M
    J Med Chem; 1998 Aug; 41(17):3232-8. PubMed ID: 9703468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total syntheses of (+)- and (-)-cacospongionolide B, cacospongionolide e, and related analogues. Preliminary study of structural features required for phospholipase a2 inhibition.
    Cheung AK; Murelli R; Snapper ML
    J Org Chem; 2004 Aug; 69(17):5712-9. PubMed ID: 15307744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manoalide.
    Soriente A; De Rosa MM; Scettri A; Sodano G; Terencio MC; Payá M; Alcaraz MJ
    Curr Med Chem; 1999 May; 6(5):415-31. PubMed ID: 10101221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Petrosaspongiolides M-R: new potent and selective phospholipase A2 inhibitors from the New Caledonian marine sponge Petrosaspongia nigra.
    Randazzo A; Debitus C; Minale L; García Pastor P; Alcaraz MJ; Payá M; Gomez-Paloma L
    J Nat Prod; 1998 May; 61(5):571-5. PubMed ID: 9599251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2.
    García Pastor P; De Rosa S; De Giulio A; Payá M; Alcaraz MJ
    Br J Pharmacol; 1999 Jan; 126(1):301-11. PubMed ID: 10051149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformationally restricted (+)-cacospongionolide B analogues. Influence on secretory phospholipase A2 inhibition.
    Murelli RP; Cheung AK; Snapper ML
    J Org Chem; 2007 Mar; 72(5):1545-52. PubMed ID: 17315974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total syntheses of (+)- and (-)-cacospongionolide B: new insight into structural requirements for phospholipase A(2) inhibition.
    Cheung AK; Snapper ML
    J Am Chem Soc; 2002 Oct; 124(39):11584-5. PubMed ID: 12296709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation.
    Glaser KB; de Carvalho MS; Jacobs RS; Kernan MR; Faulkner DJ
    Mol Pharmacol; 1989 Nov; 36(5):782-8. PubMed ID: 2586492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLA2 inhibitory activity of marine sesterterpenoids cladocorans, their diastereomers and analogues.
    Miyaoka H; Yamanishi M; Mitome H
    Chem Pharm Bull (Tokyo); 2006 Feb; 54(2):268-70. PubMed ID: 16462082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation.
    Garcia-Pastor P; Randazzo A; Gomez-Paloma L; Alcaraz MJ; Paya M
    J Pharmacol Exp Ther; 1999 Apr; 289(1):166-72. PubMed ID: 10087000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scalaradial, a dialdehyde-containing marine metabolite that causes an unexpected noncovalent PLA2 Inactivation.
    Monti MC; Casapullo A; Cavasotto CN; Napolitano A; Riccio R
    Chembiochem; 2007 Sep; 8(13):1585-91. PubMed ID: 17691073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of trimethoxyphenyl isoxazolidines as inhibitors of secretory phospholipase A2 with anti-inflammatory activity.
    Sadashiva MP; Nataraju A; Mallesha H; Rajesh R; Vishwanath BS; Rangappa KS
    Int J Mol Med; 2005 Nov; 16(5):895-904. PubMed ID: 16211261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new cacospongionolide inhibitor of human secretory phospholipase A2 from the Tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides.
    De Rosa S; Crispino A; De Giulio A; Iodice C; Benrezzouk R; Terencio MC; Ferrándiz ML; Alcaraz MJ; Payá M
    J Nat Prod; 1998 Jul; 61(7):931-5. PubMed ID: 9677277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of phospholipase A2 inhibition by petrosaspongiolide M.
    Dal Piaz F; Casapullo A; Randazzo A; Riccio R; Pucci P; Marino G; Gomez-Paloma L
    Chembiochem; 2002 Jul; 3(7):664-71. PubMed ID: 12325001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological evaluation of a selected library of new potential anti-inflammatory agents bearing the gamma-hydroxybutenolide scaffold: a new class of inhibitors of prostanoid production through the selective modulation of microsomal prostaglandin E synthase-1 expression.
    Guerrero MD; Aquino M; Bruno I; Terencio MC; Paya M; Riccio R; Gomez-Paloma L
    J Med Chem; 2007 May; 50(9):2176-84. PubMed ID: 17407277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of phospholipase A2 by manoalide. Localization of the manoalide binding site on bee venom phospholipase A2.
    Glaser KB; Vedvick TS; Jacobs RS
    Biochem Pharmacol; 1988 Oct; 37(19):3639-46. PubMed ID: 3178877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of venom phospholipases A2 by manoalide and manoalogue. Stoichiometry of incorporation.
    Reynolds LJ; Mihelich ED; Dennis EA
    J Biol Chem; 1991 Sep; 266(25):16512-7. PubMed ID: 1885583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of manoalide on secreted and intracellular phospholipases.
    Bennett CF; Mong S; Clarke MA; Kruse LI; Crooke ST
    Biochem Pharmacol; 1987 Mar; 36(5):733-40. PubMed ID: 3103628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Manoalide: a new phospholipase A2 inhibitor of marine origin with potential immunoregulatory effect].
    Mayer AM
    Medicina (B Aires); 1989; 49(2):175-80. PubMed ID: 2640487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pharmacology of manoalide. Inactivation of bee venom phospholipase A2.
    Glaser KB; Jacobs RS
    Biochem Pharmacol; 1986 Feb; 35(3):449-53. PubMed ID: 3947381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.